| Drug General Information |
| Drug ID |
D06ETI
|
| Former ID |
DCL000415
|
| Drug Name |
ABT-263
|
| Synonyms |
Navitoclax; ABT 263; S1001_Selleck; ABT263, Navitoclax; 4-(4-{[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({4-({(1R)-3-morpholin-4-yl-1-[(phenylsulfanyl)methyl]propyl}amino)-3-[(trifluoromethyl)sulfonyl]phenyl}sulfonyl)benzamide
|
| Drug Type |
Small molecular drug
|
| Company |
Roche; Genentech
|
| Formula |
C47H55ClF3N5O6S3
|
| InChI |
InChI=1S/C47H55ClF3N5O6S3/c1-46(2)20-18-42(34-8-12-37(48)13-9-34)36(31-46)32-55-22-24-56(25-23-55)39-14-10-35(11-15-39)45(57)53-65(60,61)41-16-17-43(44(30-41)64(58,59)47(49,50)51)52-38(19-21-54-26-28-62-29-27-54)33-63-40-6-4-3-5-7-40/h3-17,30,38,52H,18-29,31-33H2,1-2H3,(H,53,57)/t38-/m1/s1
|
| InChIKey |
JLYAXFNOILIKPP-KXQOOQHDSA-N
|
| CAS Number |
CAS 119229-65-1
|
| PubChem Compound ID |
|
| PubChem Substance ID |
56311703, 56314453, 57304426, 57504587, 87219189, 87457108, 96099448, 99003698, 99245529, 99246089, 99431767, 99460835, 103640740, 104115920, 124756924, 124899202, 124899203, 125163731, 126583646, 126667000, 126724167, 131465096, 131465716, 134221945, 135263748, 135626669, 135727392, 136920253, 137126833, 141663047, 143499177, 152035716, 152164573, 152240012, 152258081, 152344157, 160646920, 162011689, 162037376, 162202714, 163123180, 163821637, 164194132, 164831796, 174007035, 174531509, 198955115, 204380851, 223388517, 223685382
|
| Target and Pathway |
| References |
